Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sunitinib Malate Capsules

Approval Number

国药准字H20213753

Company齐鲁制药（海南）有限公司

Registration Date

September 30, 2021

Drug Information

Generic Name

苹果酸舒尼替尼胶囊

Dosage Form

胶囊剂

Strength

12.5mg（按C22H27FN4O2计）

Drug Type

化学药品

Registration Date

September 30, 2021

Company Information

Applicant Company

Company Name齐鲁制药（海南）有限公司

Company Address

海口市国家高新区南海大道273号-A

Manufacturing Company

Company Name齐鲁制药（海南）有限公司

Company Address

海口市国家高新区南海大道273号-A

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy